Vaccines and therapeutics for immunocompromised patients with COVID-19

The COVID-19 pandemic has disproportionately impacted immunocompromised patients. This diverse group is at increased risk for impaired vaccine responses, progression to severe disease, prolonged hospitalizations and deaths. At particular risk are people with deficiencies in lymphocyte number or func...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoham, Shmuel, Batista, Carolina, Ben Amor, Yanis, Ergonul, Onder, Hassanain, Mazen, Hotez, Peter, Kang, Gagandeep, Kim, Jerome H., Lall, Bhavna, Larson, Heidi J., Naniche, Denise, Sheahan, Timothy, Strub-Wourgaft, Nathalie, Sow, Samba O., Wilder-Smith, Annelies, Yadav, Prashant, Bottazzi, Maria Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091856/
https://www.ncbi.nlm.nih.gov/pubmed/37070102
http://dx.doi.org/10.1016/j.eclinm.2023.101965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091856/
https://www.ncbi.nlm.nih.gov/pubmed/37070102
http://dx.doi.org/10.1016/j.eclinm.2023.101965

Ejemplares similares